Header Logo

Connection

CHANDRA BARTHOLOMEUSZ to Cyclin-Dependent Kinase Inhibitor p16

Back to Details
This is a "connection" page, showing publications CHANDRA BARTHOLOMEUSZ has written about Cyclin-Dependent Kinase Inhibitor p16.
CHANDRA BARTHOLOMEUSZ
Connection Strength
0.023
Cyclin-Dependent Kinase Inhibitor p16
  1. Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells. Oncogene. 2014 Jan 23; 33(4):440-8.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.